September 2011

Customer Centric Segmentation

August 29, 2011

Marketers are zeroing in on physician and patient targets with new media, new segmentation techniques, and new analytics. Segmentation has gone micro these days, and the ability to target a very specific audience is easier than ever. However, the life-sciences industry has yet to wholly align its marketing strategies with new technologies and their capabilities. […]

The Impact of an Integrated Execution Environment on Data Management in Adaptive Clinical Trials

August 29, 2011

Contributed By Corey B. Dunham, VP Data Management and Statistics, North America Anyone who has baked a cake can tell you that the quality of the ingredients is equally as important as following the recipe. Data quality in clinical trials is much the same way. You can follow the protocol and standard operating procedures completely […]

Decoding Data Dynamics

August 29, 2011

By Carolyn Gretton The shift in life-sciences development toward more personalized therapeutics is driving a need for proactive clinical data management (CDM) strategies that take into account the volume and complexity of information emerging from today’s clinical trials. Data management is being impacted by a number of variables — more data, technology, expertise — but […]

Hola Mexico: Pharma Drawn to U.S. Neighbor

August 29, 2011

By Kim Ribbin Growing health coverage, high medical standards, a ­motivated patient population, and huge geographic ­advantages make Mexico an appealing market for the ­pharmaceutical industry. With a population of around 110 million people and a growing focus on healthcare, Mexico has fast become a profitable market for the pharmaceutical industry. The Mexican pharmaceutical industry […]

Beyond Stem Cells

August 29, 2011

By Denise Myshko It may seem like science fiction: a trachea grown from stem cells and implanted into a human being. But it’s not; this is an actual account of the power of stem cells and regenerative medicine. The 36-year-old patient, who had been suffering from late-stage tracheal cancer, received his new trachea in June […]

Mentoring: More Crucial Than Ever

August 29, 2011

By Robin Robinson With the industry in constant flux, industry leaders say mentoring is key for career advancement. Declining budgets, the emergence of small innovative startups with fewer resources, busy schedules, and an ever-changing work environment are a few of the factors that make mentoring more important to career development than ever before. Mentoring has […]

The New Frontier: Therapeutic Vaccines

August 29, 2011

By Denise Myshko Researchers continue to evaluate the sustainability of powering the immune system to treat cancers and other serious diseases. For years researchers have been trying to find a way to trigger the body’s immune system to recognize cancers and other diseases. Early attempts to use cytokines, proteins, peptides, and immune stimulants as effective […]

Public Service: Improving Adherence

August 29, 2011

By Robin Robinson For the next three years, the National Consumer League and its 100 partners will focus on improving adherence for chronic diseases. With almost 75% of patients in the United States not taking medicine as prescribed by their doctors, the public awareness campaign, Script Your Future, has a big job ahead. The campaign, […]

Last Word

August 29, 2011

Making Strategic Alliances Work Wa’el Hashad, VP, U.S. Cardiovascular and Metabolic Disorders, at Boehringer Ingelheim Pharmaceuticals, talks about how an alliance with Lilly helped to bring a new product to the diabetes market. PV: What challenges are encountered when ­developing diabetes products? Hashad: Diabetes is a common disease. There are about 24 million people who […]

Talent Pool

August 29, 2011

Executive appointments and promotions in the healthcare industry By Carolyn Gretton Pharmaceutical POOL Dr. Tomas BOCANEGRA Pozen Appoints Development VP Pozen, a pharmaceutical company committed to developing medicines that transform lives, has named Tomas Bocanegra, M.D., executive VP of development. Dr. Bocanegra is responsible for driving all product development activities at Pozen beginning with the […]

Tools of the Trade

August 29, 2011

New electronic and web-based applications, sites, and technologies By Carolyn Gretton Clinical Force Acquisition Strengthens Medidata’s CTMS Offerings Trends: E-clinical solutions providers continue to bolster their clinical trial management solutions (CTMS) offerings as demand surges amid increased use of collaborative tools by sponsors and CROs for clinical study and regulatory document management. With the acquisition […]

PharmaTrax

August 29, 2011

Sales, marketing, And R&D Trends affecting the healthcare industry By Carolyn Gretton U.S. Prescription Drug Spending Posts Modest Increase for 2010 Trend: Fewer physician office visits and new therapy starts indicate that U.S. patients are scaling back their use of prescription medicines amid the continued economic slowdown. In its recent study, The Use of Medicines […]

Social Media

August 29, 2011

Social Media trends, regs, and apps By Robin Robinson FDA Expands its Use of Social Media Trend Watch: Government agency hosts tweetchat on proposed rule for mobile apps Proposed Rule for Medical Apps Only Applies to Two Categories The proposed federal regulations regarding mobile medical applications will create little change for most app manufacturers, so […]

What’s New

August 29, 2011

New healthcare-related products, services, and companies BIO Continues Strategic Initiatives to Speed Scientific Breakthroughs Trends: Despite the current constrained economic environment, industry leaders and ­advocates continue to formulate strategies and solutions aimed at transforming policy and ­incentivizing investment in the biotech sector. The Biotechnology Industry Organization (BIO) has released a summary of legislative proposals designed […]

UpFront

August 29, 2011

UpFront Awards… » CSL Behring Receives NORD Award CSL Behring has received the ­National ­Organization for Rare Disorders (NORD) 2011 Corporate Award for new ­treatments brought to market for patients with rare diseases. CSL Behring’s new treatment, Factor XIII concentrate (human), is approved for the routine prophylactic ­treatment of congenital factor XIII ­deficiency, a rare […]

Letter from the Editor

August 29, 2011

The New Market Frontier New segmentation techniques might just be the way to uncover the next growth opportunity for brands. Audience segmentation has been around forever and is used by most companies to identify those consumers who are the right fit for their brands — and companies are spending big bucks for these insights. As […]

FEEDBACK